Skip to main content
Journal cover image

Influence of study discontinuation during the run‐in period on the estimated efficacy of sacubitril/valsartan in the trial

Publication ,  Journal Article
Suzuki, K; Claggett, B; Minamisawa, M; Packer, M; Zile, MR; Pfeffer, MA; Chiang, L; Lefkowitz, M; McMurray, JJV; Solomon, SD; Desai, AS
Published in: European Journal of Heart Failure
December 2021

Duke Scholars

Published In

European Journal of Heart Failure

DOI

EISSN

1879-0844

ISSN

1388-9842

Publication Date

December 2021

Volume

23

Issue

12

Start / End Page

2085 / 2090

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Suzuki, K., Claggett, B., Minamisawa, M., Packer, M., Zile, M. R., Pfeffer, M. A., … Desai, A. S. (2021). Influence of study discontinuation during the run‐in period on the estimated efficacy of sacubitril/valsartan in the PARAGON‐HF trial. European Journal of Heart Failure, 23(12), 2085–2090. https://doi.org/10.1002/ejhf.2262
Suzuki, Kota, Brian Claggett, Masatoshi Minamisawa, Milton Packer, Michael R. Zile, Marc A. Pfeffer, Lu‐May Chiang, et al. “Influence of study discontinuation during the run‐in period on the estimated efficacy of sacubitril/valsartan in the PARAGON‐HF trial.” European Journal of Heart Failure 23, no. 12 (December 2021): 2085–90. https://doi.org/10.1002/ejhf.2262.
Suzuki K, Claggett B, Minamisawa M, Packer M, Zile MR, Pfeffer MA, et al. Influence of study discontinuation during the run‐in period on the estimated efficacy of sacubitril/valsartan in the PARAGON‐HF trial. European Journal of Heart Failure. 2021 Dec;23(12):2085–90.
Suzuki, Kota, et al. “Influence of study discontinuation during the run‐in period on the estimated efficacy of sacubitril/valsartan in the PARAGON‐HF trial.” European Journal of Heart Failure, vol. 23, no. 12, Oxford University Press (OUP), Dec. 2021, pp. 2085–90. Crossref, doi:10.1002/ejhf.2262.
Suzuki K, Claggett B, Minamisawa M, Packer M, Zile MR, Pfeffer MA, Chiang L, Lefkowitz M, McMurray JJV, Solomon SD, Desai AS. Influence of study discontinuation during the run‐in period on the estimated efficacy of sacubitril/valsartan in the PARAGON‐HF trial. European Journal of Heart Failure. Oxford University Press (OUP); 2021 Dec;23(12):2085–2090.
Journal cover image

Published In

European Journal of Heart Failure

DOI

EISSN

1879-0844

ISSN

1388-9842

Publication Date

December 2021

Volume

23

Issue

12

Start / End Page

2085 / 2090

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology